Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500315 · ClinicalTrials.gov registry record · NA
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT03500315: Completed NA study, sponsored by Johns Hopkins University.
NCT03500315 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 209 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03500315, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine if an HIV-infected deceased kidney donor (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complications.
Interventions
- OTHER HIV D+/R+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2018-04-19 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500315
The ClinicalTrials.gov registry entry for NCT03500315 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HIV D+/R+ is the first listed.
NCT03500315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03500315 about?
NCT03500315 is a clinical study titled "HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients". The primary objective of this study is to determine if an HIV-infected deceased kidney donor (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complications.
What is the current status of trial NCT03500315?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2018-04-19. Estimated completion is 2024-05-01.
What interventions are being tested in trial NCT03500315?
The interventions under investigation include: HIV D+/R+ (OTHER).
Who is sponsoring clinical trial NCT03500315?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.